Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 6CNS 4NET 2Gastrointestinal 2Dermatologic 1

Conditions

Colorectal Neoplasms 9Pancreatic Neoplasms 6Ovarian Neoplasms 5Sarcoma 4Neuroblastoma 4Liver Neoplasms 4Wilms Tumor 3Somatostatinoma 3Rectal Neoplasms 3Osteosarcoma 3Neuroendocrine Tumors 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Medulloblastoma 3Gastrointestinal Stromal Tumors 3Esophageal Neoplasms 3Astrocytoma 3Zollinger-Ellison Syndrome 2Vipoma 2Testicular Neoplasms 2Teratoma 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Pheochromocytoma 2Ovarian Germ Cell Cancer 2Optic Nerve Glioma 2Oligodendroglioma 2Neoplasm Metastasis 2Melanoma 2

Interventions

Temozolomide 2Radiotherapy 2Capecitabine 2veliparib 1tipifarnib 1lutetium Lu 177 dotatate 1guadecitabine 1fostamatinib 1copper dotatate CU-64 1Tamoxifen 1Specimen Handling 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Oxaliplatin 1Nivolumab 1Molecular Diagnostic Techniques 1Melphalan 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Lutetium 1Leucovorin 1Ipilimumab 1Indinavir 1Immunotherapy 1Fluorodeoxyglucose F18 1Floxuridine 1Drug Therapy 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pheochromocytoma × Temozolomide × Gastrointestinal × Clear all
NCT02831179 2017-09-28

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Vanderbilt-Ingram Cancer Center

Phase 1 Withdrawn
DermatologicEndocrineGastrointestinalNET

Non functioning pancreatic endocrine tumor, Adrenal Cortex Neoplasms, Carcinoid Tumor, Vipoma, Glucagonoma, Insulinoma, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Carcinoma, Merkel Cell, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Multiple Endocrine Neoplasia Type 2b

NCT00869050 2016-07-25

Capecitabine and Temozolomide for Neuroendocrine Cancers

Columbia University

Phase 2 Completed
41 enrolled 9 charts
EndocrineGastrointestinalNET

Carcinoid Tumor, Vipoma, Pancreatic Neoplasms, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡